Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), announced on October 17, 2022, a Medical Device Correction for all Omnipod DASH® Personal Diabetes Managers (PDMs) distributed globally. This action was taken voluntarily with the knowledge of the FDA and other regulatory agencies.

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/insulet-issued-voluntary-medical-device-correction-omnipod-dashr-personal-diabetes-manager-october